THERABIOGEN, INC. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 29 rows, 29 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-09-06: Reporting owner Hensley Charles; Form 3; Security Therabiogen, Inc. (TRAB.OB); Transaction Holding.
- 2011-08-26: Reporting owner Hensley Charles; Form 4; Security Therabiogen, Inc. (TRAB.OB); Transaction C Conversion of derivative security.
- 2011-08-26: Reporting owner Hensley Charles; Form 4; Security Therabiogen, Inc. (TRAB.OB); Transaction C Conversion of derivative security.
- 2011-08-25: Reporting owner Hensley Charles; Form 4; Security Therabiogen, Inc. (TRAB.OB); Transaction S Open market or private sale of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-09-06 holding as of filing | Hensley Charles 10% Owner | 3 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | Holding | 7,479,300 owned after | no price filed | 2011-09-06 | |
| 2011-08-26 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | C Conversion of derivative security | +18,411 | $0.07 | 2011-09-06 | |
| 2011-08-26 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | C Conversion of derivative security | +20,000 | $0.05 | 2011-09-06 | |
| 2011-08-25 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −20,000 | $0.05 | 2011-09-06 | |
| 2011-08-23 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −18,411 | $0.07 | 2011-09-06 | |
| 2011-08-17 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −46,760 | $0.04 | 2011-09-06 | |
| 2011-08-12 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −7,000 | $0.04 | 2011-09-06 | |
| 2011-08-11 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −20,000 | $0.04 | 2011-09-06 | |
| 2011-07-11 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −10,000 | $0.11 | 2011-09-06 | |
| 2011-07-08 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −20,000 | $0.12 | 2011-09-06 | |
| 2011-07-08 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −10,000 | $0.12 | 2011-09-06 | |
| 2011-06-30 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −30,000 | $0.14 | 2011-09-06 | |
| 2011-06-29 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −10,000 | $0.15 | 2011-09-06 | |
| 2011-06-28 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −19,000 | $0.15 | 2011-09-06 | |
| 2011-06-27 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −30,000 | $0.15 | 2011-09-06 | |
| 2011-06-24 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −75,000 | $0.16 | 2011-09-06 | |
| 2011-06-23 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −4,500 | $0.13 | 2011-09-06 | |
| 2011-06-22 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −18,000 | $0.13 | 2011-09-06 | |
| 2011-06-20 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −13,000 | $0.15 | 2011-09-06 | |
| 2011-06-01 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −2,600 | $0.23 | 2011-09-06 | |
| 2011-05-31 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −16,000 | $0.20 | 2011-09-06 | |
| 2011-05-25 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | C Conversion of derivative security | +8,000 | $0.30 | 2011-09-06 | |
| 2011-05-25 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −8,000 | $0.30 | 2011-09-06 | |
| 2011-05-24 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −8,000 | $0.30 | 2011-09-06 | |
| 2011-05-18 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | C Conversion of derivative security | +15,000 | $0.38 | 2011-09-06 | |
| 2011-05-18 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | C Conversion of derivative security | +10,000 | $0.31 | 2011-09-06 | |
| 2011-05-18 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −10,000 | $3,400.00 | 2011-09-06 | |
| 2011-05-16 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −10,000 | $0.31 | 2011-09-06 | |
| 2011-05-13 | Hensley Charles 10% Owner | 4 | Therabiogen, Inc. (TRAB.OB) Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −15,000 | $0.38 | 2011-09-06 |